Drreddys Laboratories | RDY - Trade Creditors


Drreddys Laboratories reported INR22.36B in Trade Creditors for its fiscal quarter ending in March of 2026.





Trade Creditors Change Date
ANI Pharmaceuticals USD 69.69M 7.11M Mar/2026
Aurora Cannabis CAD 9.31M 58.72M Mar/2026
Bayer EUR 6.59B 496M Mar/2026
Canopy Growth CAD 34.82M 14.85M Mar/2026
Cipla INR 32.3B 1.95B Mar/2026
Corcept Therapeutics USD 33.31M 7.14M Mar/2026
Drreddys Laboratories INR 22.36B 21.91B Mar/2026
GlaxoSmithKline GBP 14.34B 1.05B Mar/2026
Hikma Pharmaceutical USD 715M 104M Dec/2025
Lonza CHF 471M 3M Dec/2024
Novartis USD 4.32B 134M Mar/2026
Pacira USD 14.01M 1.14M Mar/2026
Phibro Animal Health USD 129.64M 3.65M Mar/2026
Prestige Brands USD 22.79M 20.15M Mar/2026
Richter Gedeon HUF 41.68B 13.96B Mar/2026
Sun Pharmaceuticals INR 73.34B 6.28B Mar/2026
Supernus Pharmaceuticals USD 10.17M 97.63M Mar/2026
Teva Pharmaceutical Industries USD 2.6B 65M Mar/2026